BioSpace News Archive

Year

• 2005
• 2006
• 2007
• 2008
• 2009
• 2010
• 2011
• 2012
• 2013
• 2014
• 2015
• 2016
• 2017
• 2018
• 2019
• 2020
• 2021
• 2022
• 2023
• 2024
• 2025
• 2026

Month

• January
• February
• March
• April
• May
• June
• July
• August
• September
• October
• November
• December

Day

• 1
• 2
• 4
• 5
• 6
• 7
• 8
• 9
• 10
• 11
• 12
• 13
• 14
• 15
• 17
• 18
• 19
• 20
• 21
• 22
• 24
• 25
• 26
• 27
• 28
• 29
• 30

• Business

  Immunovaccine to Hold Webcast and Conference Call to Discuss Clinical Data From Its Collaborative Combination Immunotherapy Trial in Advanced Ovarian Cancer

  The purpose of this conference call is to share top-line clinical data from its ongoing Phase 1b trial evaluating the safety and efficacy of Immunovaccine’s lead immuno-oncology candidate.

  December 5, 2017

   · 

  2 min read
• Drug Development

  LAM Therapeutics Announces Progress of its Clinical Portfolio with FDA Clearance of New Trial in Leukemia and Advancement of Clinical Trial in Lymphoma

  LAM Therapeutics advanced its clinical portfolio with the FDA clearance of LAM’s IND application for LAM-003 in leukemia patients.

  December 5, 2017

   · 

  3 min read
• Biotech Beach

  Cianna Medical Launches Comprehensive Support Program to Support Health Systems’ Mission of ‘Moving Beyond Wires’ for Breast Tumor Localization

  The company introduced the program at the 2017 San Antonio Breast Cancer Symposium taking place from December 5-9, 2017, in San Antonio, Texas.

  December 5, 2017

   · 

  4 min read
• Business

  Agios Appoints Jacqualyn Fouse, Ph.D., to the Board of Directors

  Dr. Fouse previously served as president and chief operating officer of Celgene Corporation until April 2017.

  December 5, 2017

   · 

  3 min read
• Biotech Bay

  Frost & Sullivan Industry Experts Host Interactive Briefing Discussing the Technologies Driving Cancer, Diabetes and Obesity Management

  The webinar will offer expert insight from Frost & Sullivan’s Vandana Iyer.

  December 5, 2017

   · 

  2 min read
• Biotech Bay

  Light Polymers Announces Next-Generation OLED Polarizer Technology

  Light Polymers is announcing a next-generation circular polarizer for OLED displays based on lyotropic liquid crystal technology. Light Polymers’ proprietary nanochemistry creates a circular polarizer at 45 µm, thinner than any competitive offering.

  December 5, 2017

   · 

  2 min read
• Drug Development

  Positive Preclinical Data from Xenon’s XEN901 Epilepsy Program to be Presented at the 71st American Epilepsy Society Annual Meeting

  XEN901 is a potent, selective Nav1.6 sodium channel inhibitor being developed by Xenon for the treatment of epilepsy.

  December 5, 2017

   · 

  4 min read
• Drug Development

  Galectin Therapeutics to Present Results From Phase IIb NASH-CX Trial on December 5, 2017

  The company will host a conference call and webcast, including a slide presentation, beginning at 8:30 a.m. ET on December 5, 2017.

  December 5, 2017

   · 

  2 min read
• Genmab to Hold 2017 R&D Update

  The meeting will include updates on daratumumab, including presentations by key opinion leaders on data from daratumumab studies presented at the 59th Annual Meeting of the American Society of Hematology (ASH).

  December 5, 2017

   · 

  4 min read
• Business

  Sunesis’ CEO Resigns, Effective Dec. 31, 2017

  Mr. Swisher will remain with the Company as a Strategic Advisor to the Board of Directors through 2018.

  December 5, 2017

   · 

  4 min read